(Q84077312)
Statements
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer (English)
M Moehler
A Mueller
J T Hartmann
M P Ebert
S E Al-Batran
P Reimer
M Weihrauch
F Lordick
S Biesterfeld
M Kabisch
D Wachtlin
P R Galle
German Arbeitsgemeinschaft Internistische Onkologie (AIO)